1. Home
  2. UBFO vs NKTR Comparison

UBFO vs NKTR Comparison

Compare UBFO & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UBFO
  • NKTR
  • Stock Information
  • Founded
  • UBFO 1987
  • NKTR 1990
  • Country
  • UBFO United States
  • NKTR United States
  • Employees
  • UBFO N/A
  • NKTR N/A
  • Industry
  • UBFO Major Banks
  • NKTR Biotechnology: Pharmaceutical Preparations
  • Sector
  • UBFO Finance
  • NKTR Health Care
  • Exchange
  • UBFO Nasdaq
  • NKTR Nasdaq
  • Market Cap
  • UBFO 175.9M
  • NKTR 160.4M
  • IPO Year
  • UBFO N/A
  • NKTR 1994
  • Fundamental
  • Price
  • UBFO $7.93
  • NKTR $0.64
  • Analyst Decision
  • UBFO
  • NKTR Strong Buy
  • Analyst Count
  • UBFO 0
  • NKTR 6
  • Target Price
  • UBFO N/A
  • NKTR $4.92
  • AVG Volume (30 Days)
  • UBFO 36.9K
  • NKTR 2.8M
  • Earning Date
  • UBFO 04-17-2025
  • NKTR 05-08-2025
  • Dividend Yield
  • UBFO 6.06%
  • NKTR N/A
  • EPS Growth
  • UBFO N/A
  • NKTR N/A
  • EPS
  • UBFO 0.77
  • NKTR N/A
  • Revenue
  • UBFO $47,362,000.00
  • NKTR $98,427,000.00
  • Revenue This Year
  • UBFO N/A
  • NKTR N/A
  • Revenue Next Year
  • UBFO N/A
  • NKTR N/A
  • P/E Ratio
  • UBFO $10.25
  • NKTR N/A
  • Revenue Growth
  • UBFO N/A
  • NKTR 9.21
  • 52 Week Low
  • UBFO $7.02
  • NKTR $0.43
  • 52 Week High
  • UBFO $10.49
  • NKTR $1.93
  • Technical
  • Relative Strength Index (RSI)
  • UBFO 38.68
  • NKTR 45.85
  • Support Level
  • UBFO $7.32
  • NKTR $0.43
  • Resistance Level
  • UBFO $8.39
  • NKTR $0.68
  • Average True Range (ATR)
  • UBFO 0.39
  • NKTR 0.08
  • MACD
  • UBFO -0.02
  • NKTR 0.01
  • Stochastic Oscillator
  • UBFO 32.11
  • NKTR 72.41

About UBFO United Security Bancshares

United Security Bancshares operates as the holding for United Security Bank. It provides commercial banking services to the business and professional community, and individuals located in Fresno, Madera, Santa Clara, and Kern Counties. It offers checking and savings accounts, deposits, mortgage loans, credit and debit cards, safe deposit boxes, automated teller machines, wire transfers, money market accounts, mobile banking, and wealth management services. The company's primary sources of revenue are interest income from loans and investment securities.

About NKTR Nektar Therapeutics

Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. In oncology, The company is focused on activating the immune system natural tumor-fighting mechanisms, and it will be studying several immuno-oncology drug candidates in the clinic for a variety of cancer indications. In immunology, it is focused on addressing imbalances in the immune system to restore the body's self-tolerance mechanisms and achieve immune homeostasis. In virology, the company believes selective immuno-modulators can be useful in addressing viral infections in people. The group derives revenue from the United States and the Rest of the World.

Share on Social Networks: